BlackRock’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
432,559
-615,166
| -59% | -$498K | ﹤0.01% | 4453 |
|
|
2025
Q1 | $805K | Sell |
1,047,725
-22,048
| -2% | -$16.9K | ﹤0.01% | 4210 |
|
|
2024
Q4 | $1.36M | Buy |
1,069,773
+11,457
| +1% | +$14.6K | ﹤0.01% | 4093 |
|
|
2024
Q3 | $2.19M | Sell |
1,058,316
-10,600
| -1% | -$21.9K | ﹤0.01% | 3919 |
|
|
2024
Q2 | $4.07M | Sell |
1,068,916
-28,558
| -3% | -$109K | ﹤0.01% | 3712 |
|
|
2024
Q1 | $5.2M | Buy |
1,097,474
+1,885
| +0.2% | +$8.94K | ﹤0.01% | 3602 |
|
|
2023
Q4 | $4.68M | Buy |
1,095,589
+27,155
| +3% | +$116K | ﹤0.01% | 3644 |
|
|
2023
Q3 | $3.3M | Buy |
1,068,434
+209,313
| +24% | +$647K | ﹤0.01% | 3767 |
|
|
2023
Q2 | $3.87M | Buy |
859,121
+436,093
| +103% | +$1.96M | ﹤0.01% | 3735 |
|
|
2023
Q1 | $2.41M | Buy |
423,028
+29,475
| +7% | +$168K | ﹤0.01% | 3885 |
|
|
2022
Q4 | $2.38M | Sell |
393,553
-65,581
| -14% | -$396K | ﹤0.01% | 3990 |
|
|
2022
Q3 | $3.03M | Sell |
459,134
-70,301
| -13% | -$465K | ﹤0.01% | 3903 |
|
|
2022
Q2 | $2.76M | Sell |
529,435
-522,525
| -50% | -$2.73M | ﹤0.01% | 4012 |
|
|
2022
Q1 | $7.26M | Buy |
1,051,960
+155,456
| +17% | +$1.07M | ﹤0.01% | 3677 |
|
|
2021
Q4 | $11.2M | Buy |
896,504
+170,542
| +23% | +$2.12M | ﹤0.01% | 3546 |
|
|
2021
Q3 | $22.7M | Buy |
725,962
+23,120
| +3% | +$722K | ﹤0.01% | 3146 |
|
|
2021
Q2 | $20.1M | Buy |
702,842
+21,117
| +3% | +$605K | ﹤0.01% | 3251 |
|
|
2021
Q1 | $29.5M | Buy |
681,725
+44,592
| +7% | +$1.93M | ﹤0.01% | 2914 |
|
|
2020
Q4 | $45.6M | Buy |
637,133
+574,683
| +920% | +$41.1M | ﹤0.01% | 2484 |
|
|
2020
Q3 | $1.88M | Buy |
+62,450
| New | +$1.88M | ﹤0.01% | 3826 |
|